Publications by authors named "Christiane Vieweg"

Claim this Profile
S
SARS-CoV-2 convalescent plasma for the controlled clinical trial "COVIC-19": Experience from collection of very high-titer plasma from superimmunized individuals.
Simone Hoffmann, Alina Seidel, Carolin Ludwig, Christiane Vieweg, Rebecca Müller

Transfusion· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective cellular and neutralizing immunity against SARS-CoV-2 after mRNA booster vaccination is associated with pDC and B cell activation.
Dorit Fabricius, Carolin Ludwig, Matthias Proffen, Janina Hägele, Judith Scholz, Christiane Vieweg

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial.
Simone Hoffmann, Eva Schrezenmeier, Maxime Desmarets, Fabian Halleck, Antoine Durrbach, Christiane Vieweg

EBioMedicine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays.
Alina Seidel, Simone Hoffmann, Bernd Jahrsdörfer, Sixten Körper, Carolin Ludwig, Christiane Vieweg

Front Immunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages.
Bernd Jahrsdörfer, Matthias Proffen, Judith Scholz, Janina Hägele, Carolin Ludwig, Christiane Vieweg

Front Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis